Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 16.21 Billion | USD 25.36 Billion | 5.1% | 2023 |
List of Figures
FIG NO. 1. Market Attractiveness Analysis, By Drug Class
FIG NO. 2. Market Attractiveness Analysis, By Gender
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Osteoporosis Drugs Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Drug Class, 2020 & 2028
FIG NO. 7. Global Osteoporosis Drugs Market for Bisphosphonates, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Osteoporosis Drugs Market for Bisphosphonates, By Country, 2020 & 2028
FIG NO. 9. Global Osteoporosis Drugs Market for Selective Estrogen Receptor Modulators (SERMs), Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Osteoporosis Drugs Market for Selective Estrogen Receptor Modulators (SERMs), By Country, 2020 & 2028
FIG NO. 9. Global Osteoporosis Drugs Market for Parathyroid Hormone Therapy (PTH) , Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Osteoporosis Drugs Market for Parathyroid Hormone Therapy (PTH) , By Country, 2020 & 2028
FIG NO. 11. Global Osteoporosis Drugs Market for Rank Ligand Inhibitors, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Osteoporosis Drugs Market for Rank Ligand Inhibitors, By Country, 2020 & 2028
FIG NO. 13. Global Osteoporosis Drugs Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Osteoporosis Drugs Market for Others, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, By Gender, 2020 & 2028
FIG NO. 16. Global Osteoporosis Drugs Market for Male, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Osteoporosis Drugs Market for Male, By Country, 2020 & 2028
FIG NO. 18. Global Osteoporosis Drugs Market for Female, Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Osteoporosis Drugs Market for Female, By Country, 2020 & 2028
FIG NO. 20. Global Osteoporosis Drugs Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Osteoporosis Drugs Market for Others, By Country, 2020 & 2028
FIG NO. 22. Global Osteoporosis Drugs Market Revenue Share, By Region, 2020 & 2028
FIG NO. 23. North America Osteoporosis Drugs Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 24. Porter’s Five Forces Analysis for Global Osteoporosis Drugs Market
FIG NO. 25. PEST Analysis for Global Osteoporosis Drugs Market
FIG NO. 26. Pricing Analysis for Global Osteoporosis Drugs Market
FIG NO. 27. Value Chain Analysis for Global Osteoporosis Drugs Market
FIG NO. 28. Company Share Analysis, 2019
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. Business Segment Revenue Share, 2020 (%)
FIG NO. 32. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Product, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology
List of Tables
TABLE NO. 1. Global Osteoporosis Drugs Market: Snapshot
TABLE NO. 2. Quarterly Osteoporosis Drugs Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Osteoporosis Drugs Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Osteoporosis Drugs Market for Bisphosphonates, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Osteoporosis Drugs Market for Selective Estrogen Receptor Modulators (SERMs), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Osteoporosis Drugs Market for Parathyroid Hormone Therapy (PTH) , by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Osteoporosis Drugs Market for Rank Ligand Inhibitors, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Osteoporosis Drugs Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Osteoporosis Drugs Market for Male, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12 Global Osteoporosis Drugs Market for Female, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13 Global Osteoporosis Drugs Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. North America Osteoporosis Drugs Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 15. North America Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 16. North America Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 17. U.S. Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 18. U.S. Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 19. Canada Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 20. Canada Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 21. Mexico Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 22. Mexico Osteoporosis Drugs Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 23. Drivers for the Osteoporosis Drugs Market: Impact Analysis
TABLE NO. 24. Restraints for the Osteoporosis Drugs Market: Impact Analysis
TABLE NO. 25. Major Buyers of Osteoporosis Drugs Market
TABLE NO. 26. Distributors/Traders List of Osteoporosis Drugs Market
TABLE NO. 27. Global Osteoporosis Drugs Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 28: Global Osteoporosis Drugs Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)
FrequentlyAsked Questions
Osteoporosis Drugs Market size is set to expand from $ 16.21 Billion in 2023
Osteoporosis Drugs Market size is set to expand from $ 16.21 Billion in 2023 to $ 25.36 Billion by 2032, with an anticipated CAGR of around 5.1% from 2024 to 2032.
Factors such as an unprecedented rise in the disease resulted in the high demand for drugs in prophylaxis and treatment of osteoporosis thus widening the growth potential over the coming years. Moreover, the geriatric population possessing high susceptibility for osteoporosis is further presumed to propel the high demand.
North America in 2020 ruled the Osteoporosis Drugs Market and was believed to be the highest income-generating area all over the globe.
The major players that are comprised in Osteoporosis Drugs Market are Novartis International AG, Eli Lilly Amgen Inc., Forteo, Novo Nordisk A/S., F. Hoffmann La Roche Ltd., and Company, Merck & Co, Inc., Actavis plc, Pfizer, Inc, and Teva Pharmaceutical Industries Ltd.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed